Translational Cancer Observational Protocol

Launched by IRCCS SAN RAFFAELE · Dec 5, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Translational Cancer Observational Protocol, is looking at how often patients with upper urinary tract urothelial carcinoma (a type of bladder cancer) experience a return of their cancer after having surgery to remove the affected parts. The study also aims to understand how this condition affects patients' quality of life after surgery. The trial is currently recruiting participants who are 18 years or older and have been diagnosed with this type of cancer and are scheduled to undergo a specific surgery called nephroureterectomy.

If you or a loved one are eligible, you can expect to provide consent to participate and share your experiences regarding your health and well-being after the surgery. This study is open to all genders, and participants will help researchers learn more about the disease and its impact on life after treatment. Your involvement could contribute valuable information that may help improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years or older
• • Upper tract urothelial cancer diagnosis
• • Indication to cancer removal through nephroureterectomy surgery
• • Ability to read and sign the informed consent
• Exclusion Criteria:
• • Age \< 18 years
• • Absence of upper tract urothelial cancer
• • Inability to read and sign the informed consent